Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).

Eliano Pio Navarese; Antonio Landi; Angelo Oliva; Raffaele Piccolo; Victor Aboyans; Dominick Angiolillo; Dan Atar; Davide Capodanno; Keith A A Fox; Sigrun Halvorsen; Stefan James; Peter Jüni; Vijay Kunadian; Sergio Leonardi; Roxana Mehran; Gilles Montalescot; Josef Niebauer; Susanna Price; Robert F Storey; Heinz Völler; Pascal Vranckx; Stephan Windecker; Marco Valgimigli

doi:10.1093/ehjcvp/pvad016

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).

Eliano Pio Navarese, Antonio Landi, Angelo Oliva, Raffaele Piccolo, Victor Aboyans, Dominick Angiolillo, Dan Atar, Davide Capodanno, Keith A A Fox, Sigrun Halvorsen, Stefan James, Peter Jüni, Vijay Kunadian, Sergio Leonardi, Roxana Mehran, Gilles Montalescot, Josef Niebauer (Co-author), Susanna Price, Robert F Storey, Heinz VöllerPascal Vranckx, Stephan Windecker, Marco Valgimigli

Institute of Sports Medicine, Prevention and Rehabilitation

Research output: Contribution to journal › Original Article › peer-review

32 Citations (Web of Science)

Original language	English
Pages (from-to)	271-290
Journal	EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
Volume	9
Issue number	3
DOIs	https://doi.org/10.1093/ehjcvp/pvad016
Publication status	Published - 2023

Keywords

DUAL-ANTIPLATELET THERAPY
OUTCOMES

Access to Document

10.1093/ehjcvp/pvad016

Cite this

Navarese, E. P., Landi, A., Oliva, A., Piccolo, R., Aboyans, V., Angiolillo, D., Atar, D., Capodanno, D., Fox, K. A. A., Halvorsen, S., James, S., Jüni, P., Kunadian, V., Leonardi, S., Mehran, R., Montalescot, G., Niebauer, J., Price, S., Storey, R. F., ... Valgimigli, M. (2023). Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 9(3), 271-290. https://doi.org/10.1093/ehjcvp/pvad016

Navarese, Eliano Pio ; Landi, Antonio ; Oliva, Angelo et al. / Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC). In: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023 ; Vol. 9, No. 3. pp. 271-290.

@article{ab3f1e13d80c42c8948fa8bb8945d8e2,

title = "Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).",

keywords = "DUAL-ANTIPLATELET THERAPY, OUTCOMES",

author = "Navarese, \{Eliano Pio\} and Antonio Landi and Angelo Oliva and Raffaele Piccolo and Victor Aboyans and Dominick Angiolillo and Dan Atar and Davide Capodanno and Fox, \{Keith A A\} and Sigrun Halvorsen and Stefan James and Peter J{\"u}ni and Vijay Kunadian and Sergio Leonardi and Roxana Mehran and Gilles Montalescot and Josef Niebauer and Susanna Price and Storey, \{Robert F\} and Heinz V{\"o}ller and Pascal Vranckx and Stephan Windecker and Marco Valgimigli",

note = "Niebauer: Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria",

year = "2023",

doi = "10.1093/ehjcvp/pvad016",

language = "English",

volume = "9",

pages = "271--290",

journal = "EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY",

issn = "2055-6837",

number = "3",

}

Navarese, EP, Landi, A, Oliva, A, Piccolo, R, Aboyans, V, Angiolillo, D, Atar, D, Capodanno, D, Fox, KAA, Halvorsen, S, James, S, Jüni, P, Kunadian, V, Leonardi, S, Mehran, R, Montalescot, G, Niebauer, J, Price, S, Storey, RF, Völler, H, Vranckx, P, Windecker, S & Valgimigli, M 2023, 'Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).', EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, vol. 9, no. 3, pp. 271-290. https://doi.org/10.1093/ehjcvp/pvad016

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC). / Navarese, Eliano Pio; Landi, Antonio; Oliva, Angelo et al.
In: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, Vol. 9, No. 3, 2023, p. 271-290.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC).

AU - Navarese, Eliano Pio

AU - Landi, Antonio

AU - Oliva, Angelo

AU - Piccolo, Raffaele

AU - Aboyans, Victor

AU - Angiolillo, Dominick

AU - Atar, Dan

AU - Capodanno, Davide

AU - Fox, Keith A A

AU - Halvorsen, Sigrun

AU - James, Stefan

AU - Jüni, Peter

AU - Kunadian, Vijay

AU - Leonardi, Sergio

AU - Mehran, Roxana

AU - Montalescot, Gilles

AU - Niebauer, Josef

AU - Price, Susanna

AU - Storey, Robert F

AU - Völler, Heinz

AU - Vranckx, Pascal

AU - Windecker, Stephan

AU - Valgimigli, Marco

N1 - Niebauer: Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria

PY - 2023

Y1 - 2023

KW - DUAL-ANTIPLATELET THERAPY

KW - OUTCOMES

U2 - 10.1093/ehjcvp/pvad016

DO - 10.1093/ehjcvp/pvad016

M3 - Original Article

C2 - 36869784

SN - 2055-6837

VL - 9

SP - 271

EP - 290

JO - EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

JF - EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IS - 3

ER -

Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D et al. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC). EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(3):271-290. doi: 10.1093/ehjcvp/pvad016